Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT05848505Completed
Randomised, double-blind trial of dexmedetomidine in tonsillar hypertrophy (2 arms). Primary endpoint: Perioperative fentanyl consumption. Started Feb 2022; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT05848505.